2-(4-methoxyphenyl)-5-(2-phenylethylamino)-4-oxazolecarbonitrile

2-(4-methoxyphenyl)-5-(2-phenylethylamino)-4-oxazolecarbonitrile, also known as **SAR138889**, is a **selective serotonin reuptake inhibitor (SSRI)**. SSRIs are a class of drugs that are used to treat depression, anxiety, and other mental health conditions.

**Why it's important for research:**

* **Novel SSRI with unique properties:** SAR138889 has shown interesting pharmacological properties compared to other SSRIs. It has a **higher affinity for the serotonin transporter (SERT)**, the protein responsible for serotonin reuptake in the brain. This could potentially translate to better efficacy and fewer side effects.
* **Preclinical studies:** Research on SAR138889 has focused on understanding its **mechanism of action** and evaluating its **potential therapeutic benefits**.
* **Potential for new treatments:** While it has not been approved for clinical use, the research on SAR138889 has contributed to our understanding of SSRIs and their potential applications. It may offer new possibilities for treating mental health conditions.

**It's crucial to remember that:**

* SAR138889 is **not commercially available** for human use.
* Research on this compound is ongoing, and its full potential remains to be determined.

**If you're interested in learning more about SSRIs or mental health research, I recommend looking for reputable sources like:**

* **The National Institute of Mental Health (NIMH)**
* **The American Psychiatric Association (APA)**
* **Peer-reviewed scientific journals**

Remember, always consult with a healthcare professional for any questions or concerns about your health or potential treatments.